RODNEY BOWEN: Open Payments
NPI 1629499082 · SOUTH BOSTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$284 in 17 payments from 8 companies in 2025. Trend: 2023 $144 · 2024 $102 · 2025 $284
Food & beverage: $284
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 7 | $117 |
| ABBVIE INC. | 3 | $47 |
| PFIZER INC. | 2 | $35 |
| ANI Pharmaceuticals, Inc. | 1 | $30 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $10 |
Products named: Dexcom G6 Transmitter, NURTEC ODT, PURIFIED CORTROPHIN GEL, QULIPTA, TRELEGY ELLIPTA, VRAYLAR, UBRELVY, JARDIANCE.
Industry payments across VA — which companies pay providers there.
